EURONEXT Aktie

 

Euronext publishes its 2025 Universal Registration Document...

Mechelen, Belgium; March 26, 2026, 21:01 CET; regulated information — Galapagos NV (Euronext & NASDAQ: GLPG) today published its annual report for the financial year 2025 and announced that its Annual Shareholders' Meeting (AGM) and an Extraordinary Shareholders' Meeting (EGM) will be held sequentially on Tuesday, April 28, 2026 at 14:00 CET and 15:00 CET at Schaliënhoevedreef 20T, 2800 Mechelen, Belgium....

Amsterdam, March 25, 2026...

 DIJON, France – 25 mars 2026 (06.00 PM CET) – CROSSJECT (ISIN : FR0011716265 ; Euronext : ALCJ), the specialty pharmaceuticals company developing emergency medicines based on its proprietary ZENEO® needle-free auto-injector platform, notably ZEPIZURE® for the emergency treatment of epileptic seizures, today announces the appointment of Lionel Seltz as Chief Financial Officer....

DIJON, France – 25 March 2026 (07:20 AM CET) – CROSSJECT (ISIN: FR0011716265; Euronext: ALCJ), a specialty pharmaceutical company developing products for emergency situations based on its proprietary ZENEO® needle-free auto-injector technology, currently in the advanced stages of development and registration of ZEPIZURE®, an injectable for the management of epileptic seizures, today publishes its financial results for the financial year ended 31 December 2025....

Oslo, 23 March 2026: BlueNord ASA (the "Company") has today held an extraordinary general meeting ("EGM") as a digital meeting through the solution Lumi AGM.   All items on the agenda were resolved in accordance with the proposals. Following this, the Company will pay a dividend of NOK 42.84 per share to shareholders as of 23 March 2026 (as registered in Euronext Securities Oslo (VPS) on 25 March 2026). Reference is made to the stock exchange announcement made by the Company on 24 February 2026 for key information relating to the cash dividend.   Minutes from the EGM is attached to...

EINDHOVEN, the Netherlands, March 23, 2026 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD – US ADR: ONWRY), the leading neurotechnology company pioneering therapies to restore movement, function, and independence in people with spinal cord injury and other movement disabilities, today announces that it will report Full-Year 2025 Financial Results and host a webcast to provide a comprehensive business update on March 31, 2026....

March 20, 2026 – Aker Solutions ASA (“Aker Solutions”) has today allocated shares to primary insiders participating in the company's employee share purchase program for 2026. Reference is made to the stock exchange release published earlier today, March 20, 2026, concerning the employee share purchase program and share allocation. For the March 2026 allocation, shares were sold at a price per share, excluding applicable discount, of NOK 43.3056 which equals the volume-weighted average share price of Aker Solutions on Euronext Oslo Børs from and including March 13, 2026, to and including...

Louvain-la-Neuve, Belgium– March 20, 2026 – IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology and the world's leading provider of radiopharmaceutical production solutions, today announced it has signed a contract with Telix Pharmaceuticals Limited (Telix; ASX: TLX, NASDAQ: TLX), a precision oncology company, for the initial order of four Cyclone® KIUBE cyclotrons at standard IBA conditions1. The systems will be installed at select RLS Radiopharmacies (RLS) sites in the United States (U.S.)....

Akelius Residential Property AB has issued a EUR 550 million senior unsecured bond. The issue has been carried out under Akelius' EMTN-program. The bond has a maturity of five years, maturing 2031-03-25. The annual fixed coupon is 3.95 percent. The bond will be listed on Euronext Dublin and has identification number XS3310459931. The notes are expected to be rated, BBB- by Standard & Poor's. Barclays has acted as sole global coordinator. 2026-03-18 Ralf Spann CEO +49 173 643 65 90 ralf.spann@akelius.de (ralf.spann@akelius.de%0b%0d)   This information is...

Mechelen, Belgium; March 117, 2026, 22:01 CET; regulated information – Galapagos NV (Euronext & NASDAQ: GLPG) received a transparency notification from Bank of America....

The Annual General Meeting of Storebrand ASA will be held on Thursday 9 April 2026 at 16.30 (CEST). The meeting will be held electronically through the general meeting portal administered by Euronext Securities Oslo. The notice, with agenda for the General Meeting, appendices including registration form, advance note and proxy is attached to this disclosure. The documents will be available the same date on Storebrand's web pages (https://www.storebrand.no/en/investor-relations/corporate-governance/details).Shareholders without possibility to attend the meeting are encouraged to vote...

Mechelen, Belgium; March 10, 2026, 22:01 CET; regulated information – Galapagos NV (Euronext & NASDAQ: GLPG) received transparency notifications from Bank of America....

NEW YORK, March 10, 2026 /PRNewswire/ -- Bloomberg Index Services Limited (Bloomberg Indices) announced an agreement with Euronext FX to include Euronext FX's Spot FX and Precious Metals transactions (Euronext FX Prints) in its Bloomberg FX Fixings (BFIX) offering. "Incorporating......

On 6 February 2026, the Financial Supervisory Authority of Norway (Finanstilsynet) approved the base prospectus, including appendices, prepared by Lerøy Seafood Group ASA (the Company) in connection with the listing on Euronext Oslo Børs of the Company's senior unsecured green bond in the amount of NOK 500 million....

Lille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland), March 9, 2026 - GENFIT (Euronext: GNFT), a biopharmaceutical company dedicated to improving the lives of patients with rare and life-threatening liver diseases, today announces that the U.S. Food and Drug Administration (FDA) has granted ODD to NTZ (nitazoxanide), its investigational small-molecule drug candidate developed as a new formulation for the treatment of Acute-on-Chronic Liver Failure (ACLF)....

Euronext announces volumes for February 2026...

Mechelen, Belgium; March 6, 2026, 22.01 CET; regulated information – Galapagos NV (Euronext & NASDAQ: GLPG) announced today that its Board of Directors created 1,750,000 subscription rights under a new subscription right plan....

Mechelen, Belgium; March 4, 2026, 22:01 CET; regulated information – Galapagos NV (Euronext & NASDAQ: GLPG) received transparency notifications from Bank of America....

HOUSTON--(BUSINESS WIRE)--Otovo (Euronext Oslo Børs: OTOVO), an AI-native energy service provider for residential and commercial customers, today announced the successful completion of a private placement raising approximately NOK 161 million (approximately $16.6 million) through the issuance of approximately 14.0 million new shares (the “Offer Shares”) at a subscription price of NOK 11.50 per Offer Share (the “Offer Price”). The financing included participation from new and existing investors, including Encompass Capital Advisors LLC (“Encompass”), acting for certain fund entities and managed accounts for which Encompass exercises investment discretion, Franklin Templeton, and Electron. The net proceeds from the private placement will be used to fund Otovo's previously announced acquisition of all shares in EnergyAid Inc., a leading provider of residential solar service and repair solutions in California, Arizona, and Nevada. A portion of the proceeds may also be used to support major OEM p...